For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Phase 1 and 2: Ruxolitinib/Trastuzumab (25 mg) | Ruxolitinib: 25 mg bid on days 1 through 21 of each 21 day cycle. Number of Cycles: until progression or unacceptable toxicity develops. Trastuzumab: 6 mg/kg every 3 weeks (cycle = 21 days). If no trastuzumab \> 28 days, patients will be initially re-loaded at 8 mg/kg, then 6 mg/kg. | 4 | None | 8 | 26 | 26 | 26 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Bone Pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Wound Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Nervous System Disorder | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dyspnea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Neoplasm | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Chest Pain | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Upper Respiratory Infection | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Thromboembolic Event | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Seizure | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Neoplasms benign, malignant and unspecified (including cysts and polyps) | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Upper respiratory infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Pain in extremity | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Muscle weakness, upper limb | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Anemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Back pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Urinary Incontinence | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Eye Disorder | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Abdominal Pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Alanine aminotransferase increase | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Alkaline phosphatase increased | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Bone Pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| CD4 lymphocytes decrease | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Chest pain- cardiac | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Chest wall pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Chills | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cholesterol high | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Confusion | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Cough | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Creatinine increase | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Cystitis noninfective | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dizziness | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dry eye | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Dry mouth | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dyspepsia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dysphagia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dyspnea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Edema face | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Edema limbs | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Ejection fraction decreased | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Electrocardiogram QT corrected interval prolonged | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Epistaxis | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fall | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fever | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Flu like symptoms | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Gait disturbance | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Gastroesophageal reflux disease | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastrointestinal disorders, other | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastroparesis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Generalized muscle weakness | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Heart failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hepatic pain | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Hoarseness | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hot flashes | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hyperglycemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hyperkalemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hypertension | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hypertriglyceridemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hypoalbuminemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hypocalcemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hyponatremia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hypophosphatemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hypoxia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Infections and infestations, other | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Infusion related reaction | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Insomnia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Localized edema | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Lung infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Lymphocyte count decreased | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Memory impairment | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Mucositis oral | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Muscle weakness upper limb | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Neck pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Nervous system disorders - Other | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Neutrophil count decreased | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Non-cardiac chest pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Oral pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Palpitations | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Paresthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Peripheral motor neuropathy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Peripheral sensory neuropathy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Platelet count decreased | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Premature menopause | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Pruritus | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Psychiatric disorders - Other | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Pulmonary edema | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Rash acneiform | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash maculo-papular | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rectal mucositis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Renal and urinary disorders - Other | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Reproductive system and breast disorders - Other | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Skin and subcutaneous tissue disorders - Other | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Skin infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sore throat | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Spasticity | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Toothache | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Transient ischemic attacks | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Tumor pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Upper respiratory infection | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Urinary tract infection | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Weight gain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Weight loss | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Wheezing | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| White blood cell decreased | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| General disorders and administration site conditions - Other, specify | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Allergic rhinitis | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Alopecia | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Anorexia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Anxiety | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Arthralgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Ascites | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Aspartate aminotransferase increase | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Bloating | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Blood and lymphatic system disorders | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Blood bilirubin increased | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Blurred vision | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |